SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

2000/08/01 by Nathalie Fouchard, M. Bertocchi, Jean‐Claude Roujeau +7 · 32 citations
Medicine · #Drug-Induced Adverse Reactions #Contact Dermatitis and Allergies #Food Allergy and Anaphylaxis Research

paper · pdf · doi:10.1046/j.1523-1747.2000.00061.x

Cited by

• Performance of the SCORTEN During the First Five Days of Hospitalization to Predict the Prognosis of Epidermal Necrolysis
• Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
• Antishear Therapy for Toxic Epidermal Necrolysis: An Alternative Treatment Approach
• Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic Strategies
• Clinical characteristics, outcome, and costs among patients in a dermatological intensive care unit: A single-center retrospective study
• Diagnosing and Managing Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017–2023
• Need for Trial Design Change in Epidermal Necrolysis (Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis): Example of Cyclosporine
• Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database. [europepmc]
• Toxic epidermal necrolysis and Stevens-Johnson syndrome. [europepmc]
• Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. [europepmc]
• Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. [europepmc]
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done. [europepmc]
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. [europepmc]
• Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. [europepmc]
• SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. [europepmc]
• Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions. [europepmc]
• Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies. [europepmc]
• Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins). [europepmc]
• An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity. [europepmc]
• Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. [europepmc]
• Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review. [europepmc]
• Multidisciplinary care in Stevens-Johnson syndrome. [europepmc]
• Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. [europepmc]
• Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis. [europepmc]
• An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity. [europepmc]
• Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction. [europepmc]
• Current Perspectives on Severe Drug Eruption. [europepmc]
• Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database. [europepmc]
• Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study. [europepmc]
• Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. [europepmc]
• Severe cutaneous adverse reactions. [europepmc]
• Spatial proteomics identifies JAKi as treatment for a lethal skin disease. [europepmc]